For decades, heart disease–particularly atherosclerosis, a condition characterized by the buildup of plaque in the artery walls–has remained the world’s top health challenge despite major medical advances. Cholesterol and high-fat diets have long shouldered the blame, but new research published in Nature uncovers an unexpected suspect: our gut microbes.
In a recent study, Mastrangelo and colleagues (2025) discovered that imidazole propionate (ImP), a molecule produced by gut bacteria during histidine digestion, significantly influences the development of atherosclerosis. Previously linked to metabolic disorders like diabetes, ImP now emerges as a direct contributor to cardiovascular disease, independent of cholesterol levels.
Using mouse models predisposed to heart disease, researchers found higher ImP levels in animals fed high-cholesterol diets. Remarkably, administering ImP directly accelerated plaque buildup, highlighting a previously unknown pathway connecting diet, gut microbes and cardiovascular health.
Digging deeper, the team revealed that ImP targets imidazoline-1 receptors (I1R) on immune cells, activating inflammatory signals via the mTORC1 pathway. This interaction intensifies inflammation within arterial walls, worsening arterial damage.
But there’s good news: blocking the I1R receptor with the compound AGN successfully reduced inflammation and plaque formation in these models, indicating a potential new therapeutic path. This discovery could complement traditional cholesterol-focused treatments, marking a major shift in how we approach cardiovascular health.
In a clear connection to human health, dietary analysis revealed that people who regularly consume fish, poultry, leafy greens, whole grains, nuts and tea showed significantly lower ImP levels. In contrast, processed food consumption was strongly associated with higher ImP levels, underscoring diet as a powerful, modifiable factor in heart disease prevention.
These findings offer a compelling new angle on cardiovascular health, transforming our understanding of how gut bacteria influence the heart. Rather than focusing solely on cholesterol, this study highlights gut microbiome health as a promising new area to explore in heart disease management. As scientists continue exploring these intricate connections, caring for your heart might soon mean caring for the bacteria within you, opening doors to innovative treatments and healthier lives.
Reference:
Mastrangelo, A., Robles-Vera, I., Mañanes, D. et al. Imidazole propionate is a driver and therapeutic target in atherosclerosis. Nature (2025). https://doi.org/10.1038/s41586-025-09263-w
Sara Millevolte
Latest posts by Sara Millevolte (see all)
- Brewing Immunity: The Vaccine Beer Experiment - January 13, 2026
- Life on Mars? Proteomic Secrets of Bacterial Survival in Martian Brines - December 11, 2025
- An Unexpected Culprit in Heart Disease? Meet Your Gut Microbes - August 14, 2025
